Trump Aims for Regulated Peptide Market
US Health Secretary Robert F Kennedy Jr stated that the administration plans to establish a regulated marketplace for popular peptides. The move follows a proposed FDA policy change regarding compounding pharmacies.
The United States administration aims to build a regulated marketplace for peptides to curb safety risks in a booming gray market. Health Secretary Robert F. Kennedy Jr. announced the policy shift on Tuesday during an interview. The initiative follows a proposed FDA policy submitted to the White House last week to ease compounding restrictions.
